| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A four week trial of hypertonic saline in children with mild cystic fibrosis lung disease: Effect on mucociliary clearance and clinical outcomes
|
Donaldson, Scott H.
|
|
|
19 |
6 |
p. 942-948
|
article
|
| 2 |
Airway profile of bioactive lipids predicts early progression of lung disease in cystic fibrosis
|
Horati, Hamed
|
|
|
19 |
6 |
p. 902-909
|
article
|
| 3 |
Antibiofilm and mucolytic action of nitric oxide delivered via gas or macromolecular donor using in vitro and ex vivo models
|
Rouillard, Kaitlyn R.
|
|
|
19 |
6 |
p. 1004-1010
|
article
|
| 4 |
Caring for gender diverse youth with cystic fibrosis
|
Kidd, Kacie M.
|
|
|
19 |
6 |
p. 1018-1020
|
article
|
| 5 |
Changes in LCI in F508del/F508del patients treated with lumacaftor/ivacaftor: Results from the prospect study
|
Shaw, Michelle
|
|
|
19 |
6 |
p. 931-933
|
article
|
| 6 |
Clinical effects of the three CFTR potentiator treatments curcumin, genistein and ivacaftor in patients with the CFTR-S1251N gating mutation
|
Berkers, Gitte
|
|
|
19 |
6 |
p. 955-961
|
article
|
| 7 |
Clinimetric evaluation of muscle function tests for individuals with cystic fibrosis: A systematic review
|
Combret, Yann
|
|
|
19 |
6 |
p. 981-995
|
article
|
| 8 |
Distal Intestinal Obstruction Syndrome resolved by dissolution with Coca-Cola® via colonoscopy in a cystic fibrosis patient
|
Ferre-Aracil, Carlos
|
|
|
19 |
6 |
p. e43-e44
|
article
|
| 9 |
Editorial Board
|
|
|
|
19 |
6 |
p. ii
|
article
|
| 10 |
From micro to macro; joining the dots of early CF lung disease
|
Linnane, Barry
|
|
|
19 |
6 |
p. 850-851
|
article
|
| 11 |
Global assessment of the integrated stress response in CF patient-derived airway and intestinal tissues
|
Bampi, Giovana B.
|
|
|
19 |
6 |
p. 1021-1026
|
article
|
| 12 |
In vivo demonstration of Pseudomonas aeruginosa biofilms as independent pharmacological microcompartments
|
Christophersen, Lars
|
|
|
19 |
6 |
p. 996-1003
|
article
|
| 13 |
Laboratory reporting on the clinical spectrum of CFTR p.Arg117His: Still room for improvement
|
Laudus, Nele
|
|
|
19 |
6 |
p. 969-974
|
article
|
| 14 |
Lung clearance index-triggered intervention in children with cystic fibrosis – A randomised pilot study
|
Voldby, Christian
|
|
|
19 |
6 |
p. 934-941
|
article
|
| 15 |
Microbicidal activity of N-chlorotaurine can be enhanced in the presence of lung epithelial cells
|
Leiter, Hannes
|
|
|
19 |
6 |
p. 1011-1017
|
article
|
| 16 |
Minimal change in structural, functional and inflammatory markers of lung disease in newborn screened infants with cystic fibrosis at one year
|
Davies, Gwyneth
|
|
|
19 |
6 |
p. 896-901
|
article
|
| 17 |
News Article
|
|
|
|
19 |
6 |
p. 856-857
|
article
|
| 18 |
Outcomes and endpoints reported in studies of pulmonary exacerbations in people with cystic fibrosis: A systematic review
|
McLeod, Charlie
|
|
|
19 |
6 |
p. 858-867
|
article
|
| 19 |
Penetrance is a critical parameter for assessing the disease liability of CFTR variants
|
Boussaroque, A.
|
|
|
19 |
6 |
p. 949-954
|
article
|
| 20 |
Predicting the course of nutrition and lung disease in infants and children with cystic fibrosis
|
McColley, Susanna A.
|
|
|
19 |
6 |
p. 847-849
|
article
|
| 21 |
Predictive effects of low birth weight and small for gestational age status on respiratory and nutritional outcomes in cystic fibrosis
|
Atteih, Samar E.
|
|
|
19 |
6 |
p. 888-895
|
article
|
| 22 |
Recommended shielding against COVID-19 impacts physical activity levels in adults with cystic fibrosis
|
Radtke, Thomas
|
|
|
19 |
6 |
p. 875-879
|
article
|
| 23 |
Regional differences in infection and structural lung disease in infants and young children with cystic fibrosis
|
Carzino, Rosemary
|
|
|
19 |
6 |
p. 917-922
|
article
|
| 24 |
Resting energy expenditure in cystic fibrosis patients decreases after lung transplantation, which improves applicability of prediction equations for energy requirement
|
Hollander-Kraaijeveld, F.M.
|
|
|
19 |
6 |
p. 975-980
|
article
|
| 25 |
Risk factors for progression of structural lung disease in school-age children with cystic fibrosis
|
Svedberg, Marcus
|
|
|
19 |
6 |
p. 910-916
|
article
|
| 26 |
SARS-CoV-2 seroprevalence in a Belgian cohort of patients with cystic fibrosis
|
Berardis, S.
|
|
|
19 |
6 |
p. 872-874
|
article
|
| 27 |
Tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for minimal function CFTR mutations
|
Munck, Anne
|
|
|
19 |
6 |
p. 962-968
|
article
|
| 28 |
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
|
McClenaghan, Elliot
|
|
|
19 |
6 |
p. 868-871
|
article
|
| 29 |
The impact of the COVID-19 pandemic on the emotional well-being and home treatment of Belgian patients with cystic fibrosis, including transplanted patients and paediatric patients
|
Havermans, Trudy
|
|
|
19 |
6 |
p. 880-887
|
article
|
| 30 |
Total bacterial load, inflammation, and structural lung disease in paediatric cystic fibrosis
|
Taylor, Steven L.
|
|
|
19 |
6 |
p. 923-930
|
article
|
| 31 |
Transjugular intrahepatic portosystemic shunt in non-cirrhotic portal hypertension related to cystic fibrosis in a lung transplant patient
|
Lupi, A.
|
|
|
19 |
6 |
p. e45-e47
|
article
|
| 32 |
Utility of lung clearance index in CF: What we know, what we don't know and musings on how to bridge the gap
|
Short, C.
|
|
|
19 |
6 |
p. 852-855
|
article
|
| 33 |
What it takes to implement regular longitudinal multiple breath washout tests in infants with cystic fibrosis
|
Schmidt, Marika N.
|
|
|
19 |
6 |
p. 1027-1028
|
article
|
Journal description